Carl Deirmengian
Fondateur chez CD Diagnostics, Inc.
Profil
Dr. Carl Deirmengian, MD, is Venture Partner & Advisor at Bio-Star Ventures.
In addition to that, Dr. Deirmengian is a practicing orthopaedic surgeon specializing in total hip and total knee replacements.
His residency in orthopaedic surgery at the University of Pennsylvania in 2005 and his Fellowship in Adult Reconstructive Surgery of the Hip and Knee at Rush University Medical Center in Chicago in 2006.
Dr. Deirmengian completed his BA in chemistry at Princeton University in 1992, his MD at Harvard Medical School in 1996
Postes actifs de Carl Deirmengian
| Sociétés | Poste | Début |
|---|---|---|
CD Diagnostics, Inc.
 CD Diagnostics, Inc. BiotechnologyHealth Technology CD Diagnostics, Inc. provides research and development about joint fluid. It is developing a series of immunoassays to detect the cause of joint pain using joint fluid. The firm's immunoassay is a test that measures the presence of a substance. The company was founded by Carl Deirmengian and Michael J. Behr in 2008 and is headquartered in Claymont, DE. | Fondateur | 01/01/2008 |
Formation de Carl Deirmengian
| Princeton University | Undergraduate Degree |
| Harvard University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
CD Diagnostics, Inc.
CD Diagnostics, Inc. BiotechnologyHealth Technology CD Diagnostics, Inc. provides research and development about joint fluid. It is developing a series of immunoassays to detect the cause of joint pain using joint fluid. The firm's immunoassay is a test that measures the presence of a substance. The company was founded by Carl Deirmengian and Michael J. Behr in 2008 and is headquartered in Claymont, DE. | Health Technology |
